The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of izalontamab (SI-B001) in combination with paclitaxel or docetaxel in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
 
Ye Guo
Honoraria - BeOne; Merck Serono; MSD; Roche
Consulting or Advisory Role - AstraZeneca; BMS; Johnson & Johnson; MSD
 
Liqiong Xue
No Relationships to Disclose
 
Bihui Li
No Relationships to Disclose
 
Jinguan Lin
No Relationships to Disclose
 
Kunyu Yang
No Relationships to Disclose
 
Meiyu Fang
No Relationships to Disclose
 
Xuelei Ma
No Relationships to Disclose
 
Sa Xiao
Employment - Baili Biopharmaceutical
Stock and Other Ownership Interests - Baili Biopharmaceutical
 
Hai Zhu
Employment - Baili Biopharmaceutical (I); Systimmune; Systimmune (I)
Leadership - Baili Biopharmaceutical (I); Systimmune; Systimmune (I)
Stock and Other Ownership Interests - Baili Biopharmaceutical (I); Systimmune; Systimmune (I)
 
Yi Zhu
Employment - Baili Biopharmaceutical; SystImmune; Systimmune (I)
Leadership - Baili Biopharmaceutical; SystImmune
Stock and Other Ownership Interests - Baili Biopharmaceutical; SystImmune; SystImmune (I)